Group Testing with Correlation under Edge-Faulty Graphs
Hesam Nikpey, Jungyeol Kim, Xingran Chen, Saswati Sarkar, Shirin, Saeedi Bidokhti

TL;DR
This paper analyzes how exploiting correlation in network-based group testing, modeled via edge-faulty graphs, can significantly reduce the number of tests needed to identify defective nodes, especially in dense or structured graphs.
Contribution
It introduces bounds on testing requirements for correlated nodes modeled by edge-faulty graphs, and provides new insights into how correlation and graph structure improve testing efficiency.
Findings
Correlation reduces the number of tests compared to independent nodes.
Improvement factors depend on graph structure, e.g., log(1/r) for trees.
Dense graphs like SBM offer scaling improvements in n.
Abstract
In applications of group testing in networks, e.g. identifying individuals who are infected by a disease spread over a network, exploiting correlation among network nodes provides fundamental opportunities in reducing the number of tests needed. We model and analyze group testing on correlated nodes whose interactions are specified by a graph . We model correlation through an edge-faulty random graph formed from in which each edge is dropped with probability , and all nodes in the same component have the same state. We consider three classes of graphs: cycles and trees, -regular graphs and stochastic block models or SBM, and obtain lower and upper bounds on the number of tests needed to identify the defective nodes. Our results are expressed in terms of the number of tests needed when the nodes are independent and they are in terms of , , and the target error.…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSARS-CoV-2 detection and testing · Data-Driven Disease Surveillance · HIV Research and Treatment
